4//SEC Filing
BERTHIAUME DOUGLAS A 4
Accession 0001225208-11-011471
CIK 0000732485other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 8:24 PM ET
Size
15.1 KB
Accession
0001225208-11-011471
Insider Transaction Report
Form 4
GENZYME CORPGENZ
BERTHIAUME DOUGLAS A
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.16/sh−15,000$932,400→ 0 totalExercise: $62.16From: 2008-05-24Exp: 2017-05-24→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition from Tender
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−4,048$299,552→ 0 total(indirect: By Spouse) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.66/sh−7,500$439,950→ 0 totalExercise: $58.66From: 2010-05-21Exp: 2019-05-21→ Genzyme common stock (GENZ) (7,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$58.50/sh−15,000$877,500→ 0 totalExercise: $58.50From: 2007-05-25Exp: 2016-05-26→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$62.98/sh−15,000$944,700→ 0 totalExercise: $62.98From: 2006-05-26Exp: 2015-05-26→ Genzyme common stock (GENZ) (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$68.48/sh−7,500$513,600→ 0 totalExercise: $68.48From: 2009-05-22Exp: 2018-05-22→ Genzyme common stock (GENZ) (7,500 underlying)
Footnotes (1)
- [F1]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.
Documents
Issuer
GENZYME CORP
CIK 0000732485
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001082257
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 8:24 PM ET
- Size
- 15.1 KB